Article Text

Novel treatment (new drug/intervention; established drug/procedure in new situation)
Response of facial haemangioma to oral propranolol
  1. Mohamad Hassan Itani1,
  2. Hadi Fakih2
  1. 1
    American University Hospital of Beirut, Pediatrics, Cairo Street, Beirut, 113-6044/29D, Lebanon
  2. 2
    Sheikh Ragheb Harb Hospital, Pediatrics, Toul Street, Nabatieh, South Lebanon, 2034-8424, Lebanon
  1. Mohamad Hassan Itani, mi28{at}


Haemangioma is the most common vascular tumour of childhood. Most cases require no therapeutic intervention, with spontaneous involution by 5–9 years of age. Some haemangiomas may become large in size impinging on vital structures such as eyes, mouth, nose or larynx, and require certain therapeutic interventions to prevent major morbidities. The usual treatments include oral/intralesional steroids, α interferon, cytotoxins, remobilisation, pulsed dye laser and cosmetic surgery resection; these treatments are not free of multiple complications and toxic side effects. This report describes the case of a 4-month-old female baby with progressively increasing haemangioma of the right upper eyelid impinging over the upper outer visual field. The haemangioma responded promptly to low-dose oral propranolol. A clinical response was noticed few days after the start of the treatment and was free of any major side effects.

View Full Text

Statistics from


  • Competing interests: none.

  • Patient consent: Patient/guardian consent was obtained for publication.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.